Liquid Chromatography-Mass Spectrometry for the Analysis of Biological Small Molecules in Metabolomic, Nutritional, and Toxicological Studies.

Lead Research Organisation: University of Leeds
Department Name: School of Medicine

Abstract

This proposal requests support for a piece of equipment called a liquid chromatography - mass spectrometer (LC-MS). This equipment allows researchers to measure the mass of particles, and to find the basic chemicals that make up a biological sample such as blood, tissue or food. The LC-MS requested in this proposal will support research from multiple scientific disciplines, and on several distinct projects of great importance to the health of the population:

Example Project 1: Given that 340 million people worldwide suffer from type 2 diabetes, finding new treatments is essential. White fat tissue stores energy as fat and releases signals into the blood which communicate with other organs, regulating whole-body metabolism. However, not all fat cells are identical. A second fat cell population, brown fat cells, regulate body temperature by "burning" stored fats, producing heat. A third fat cell population, beige fat, can switch from behaving like white fat cells (storing fat) to functioning like brown fat cells (burning fat), a process called "browning". In humans, beige fat may form the majority of this heat-producing tissue, and is also found within white fat tissue. Beige fat has anti-diabetic properties which may, in part, occur through release of signals into the blood which alter metabolism in tissues such as liver, muscle and white fat.
This research will use the requested LC-MS to determine whether browning of white fat tissue results in metabolite signal secretion, and to identify these signals. The capacity of metabolite signals to induce browning in neighbouring white fat tissue and to signal, via the blood, to other organs to regulate whole-body metabolism, will be investigated. This research may identify beige cell-specific metabolite signals, with anti-obesity properties, and provide new anti-diabetic therapies.

Example Project 2: Food constituents can have profound effects on wide ranging aspects of health including gut function, control of blood glucose and our ability to think. Wheat and other food crops contain naturally occurring compounds, called phenols, which may have anti-oxidant effects that reduce cellular damage to DNA known to be important in cancer and ageing. They may also improve gut function. This project will use the LC-MS to measure the antioxidant phenols, and micronutrients in models of gut function to understand how readily these antioxidant phenols are absorbed from food, determine ways of improving their uptake, and to measure the absorption of other micronutrients across the gut in the presence of the phenols to determine how they affect gut nutrient uptake.

Example Project 3: Food contaminants and toxins are a major risk to human health and have particular impact on vulnerable communities in low income countries. A particular group of toxins know as mycotoxins, derived from fungus, can contaminate food crops such as maize and wheat and have been linked to reduced child growth and development, and the development of cancer. This project will use the requested LC-MS to measure levels of the toxins and markers of exposure to the toxins in human populations from Africa to understand distribution patterns of contamination in different crops, storage conditions and geographic locations and to assess the effectiveness of interventions to reduce mycotoxin risk in Africa. Therefore contributing to the safety and security of the global food industry.

Example Project 4: Exposure to environmental pollution in the form of particulates from traffic in the air can alter the way in which blood clots and contribute to deep vein thrombosis. This project will use the requested LC-MS to measure markers of exposure to the particle pollutants in blood samples of the population to understand the effects of pollution on cardiovascular health.

Technical Summary

This proposal seeks a Waters Xevo TQ-XS Liquid Chromatography-Mass Spectrometry (LC-MS) system to enhance analytical chemistry applied specifically to biological small molecules across research priorities central to both the Faculty of Mathematics and Physical Sciences (MAPS) and the Faculty of Medicine and Health (FMH) at the University of Leeds.
The LC-MS is a liquid chromatograph coupled to a tandem quadrupole mass spectrometer capable of both electrospray and atmospheric pressure chemical ionization, utilized for the mass separation, identification and quantification of a range of small molecules, including metabolites, lipids, drugs and chemical contaminants within biological samples. This LC-MS system offers advanced sensitivity and reliability of detection with straightforward maintenance and intuitive data processing. The LC-MS is capable of cross-discipline small molecule applications including nutritional, cellular, toxicological and drug metabolite analysis. Within the FMH the LC-MS system will support research including metabolomics approaches in tissue culture and rodent models, and human intervention studies, to investigate the pathophysiology of cardiometabolic diseases; the metabolism of adipose tissue; and the contribution of nutritional and environmental factors to the prevention of metabolic disease. Within MAPS the LC-MS will support research in food safety, from chemical toxin analysis in food matrices, to biomonitoring of human exposure to dietary chemical contaminants; a vital step towards assessing and preventing unsafe exposure from food and environment, and understanding how exposure contributes to non-communicable disease in society.
The LC-MS system will support research of global importance to population health and wealth creation whilst aligning with BBSRC Strategic Research Priority, "Bioscience Underpinning Health" and BBSRC Responsive Mode Priorities; "Food, Nutrition and Health", and "Healthy Ageing across the Lifecourse".

Planned Impact

This statement sets out how the Liquid Chromatography - Mass Spectrometer (LC-MS) requested in this proposal will be translated into improvements in human health, and benefits to UK competitiveness and wealth. Objectives include the dissemination of the research to potential beneficiaries, policy makers, industry, and the public through both direct and indirect engagement.
Research generated using the LC-MS will create scientific impact for a scientific audience. The outputs will include peer-reviewed publications throughout the instrument lifetime, adhering to BBSRC open access policy. The applicants have experience publishing in high impact journals (e.g. Cell Metabolism, Diabetes and The Lancet). Impact will also include conference proceedings. This will be complemented by PI and Co-I membership of scientific bodies (e.g. European Association for the Study of Diabetes, EASD). The research will be reported at both broad interest international conferences (e.g. EASD Annual Meeting) and specialised conferences (Metabolomics Society). Impact will also be via data sharing. Metabolomic data will be made accessible on databases (e.g. MetaboLights) not more than 2 years post study completion. These outputs will impact wider research into the role of adipose tissue in the aetiology and treatment of metabolic diseases of global importance; the understanding of bioactive nutritional small molecules and their role in human health and disease; and the identification of food contaminants and toxins and their importance to food safety and toxicology.
The research supported by the LC-MS may lead to the discovery of novel therapeutics for metabolic diseases, yield improvements in food processing and selection with impacts on population health and food industry wealth, and may have significant impact on food safety and toxicology, and the understanding of the impact of pollution on cardiovascular health. Intellectual property (IP) generated from these research approaches will be exploited through patent protection, commercial partnering and licensing. Interaction with industry may facilitate the transition from discovery to commercialisation; this transition can run to decades. However, shorter term goals such as patent application will occur over a shorter period (3 - 5 years). The generation, protection and exploitation of IP will be facilitated by interactions with the university IP agent.
Research using the LC-MS may influence national and international public policy. This research may influence dietary and dietary supplement advice and influence policy on food system and pollution management and food safety. This will have a significant impact on the health of society and could reduce the economic burden on healthcare by informing policy makers in Public Health England, UK Departments of Health, Department for Environment Food and Rural Affairs, NICE and the NHS.
The LC-MS would have a continuing impact on the UK economy by providing a training platform to instruct graduate students in the application of analytical chemistry techniques in biological research. Projects will be offered through PhD training schemes (MRC and BBSRC Doctoral Training Partnerships) offering training for the next generation of scientists in cutting edge mass spectrometry-based biological techniques.
Infrastructure Impact - In the long-term (5 - 10 years) the LC-MS will provide the catalyst for impact to university infrastructure in the form of a small mass spectrometry and metabolic phenotyping facility/core, closely linked to the School of Food Science and Nutrition (FSN) strategic plan to build a "food safety" suite. The equipment will contribute to shaping new research direction in the FSN towards an international leading research centre in food safety, dietary health, and sustainable food systems.
Regional Impact - The LC-MS will also impact the research of our N8 regional partners in the most research intensive universities in Northern England.

Publications

10 25 50
 
Description The equipment funded through this grant has been used in numerous publications thus far (8). These have identified mechanisms through which inorganic nitrate, a compound found in green leafy vegetables improves glucose uptake and disposal in fat tissue that may be important in Diabetes and Obesity research. The publications associated with this equipment grant also detail new scientific methodologies aimed at the simultaneous analysis of both proteins and metabolites from the same patient clinical sample (simultaneous metabolomics and proteomics) which is likely to be important for biotechnology and clinical purposes. We have also identified the ways in which obesity alters the function of the membrane of fat cells which may contribute to deleterious health effects in obesity.
Exploitation Route Our findings detailed above related to inorganic nitrate may be used in clinical practice by both physicians and dietitians to recommend changes to dietary habits for patients with obesity and diabetes. These concepts may also be taken forward by clinicians in clinical trials of inorganic nitrate to alleviate symptoms of diabetes and obesity in patients. Our new published methods for simultaneous metabolomics and proteomics may be taken forward by researchers and clinicians performing analyses of rare human tissue clinical samples that may require sparing use and in the biotechnology and pharmaceutical industries.
Sectors Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology

 
Description Findings from this research have been used to develop new research methods with industrial partners. With Waters Corporation: LipidQuan: Quantifying the Lipidome of Transgenic Mice Tissue Extracts, a Rapid and Comprehensive Targeted Approach (https://www.waters.com/nextgen/gb/en/library/application-notes/2020/LipidQuan-Quantifying-the-Lipidome-of-Transgenic-Mice-Tissue-Extracts,-a-Rapid-and-Comprehensive-Targeted-Approach.html) With Protifi LLC: Detergent-Free Simultaneous Sample Preparation Method for Proteomics and Metabolomics (https://pubs.acs.org/doi/full/10.1021/acs.jproteome.9b00662).
First Year Of Impact 2020
Sector Chemicals,Manufacturing, including Industrial Biotechology
Impact Types Economic

 
Description Does the exercise-regulated myokine ß-aminoisobutyric acid protect against skeletal muscle dysfunction in diabetes?
Amount £269,578 (GBP)
Funding ID 19/0006049 
Organisation Diabetes UK 
Sector Charity/Non Profit
Country United Kingdom
Start 04/2020 
End 03/2023
 
Description Is the exercise-regulated myokine-like small molecule beta-aminoisobutyric acid a paracrine signal and exercise mimetic?
Amount £508,005 (GBP)
Funding ID BB/T004231/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 01/2020 
End 12/2022
 
Description Lipokines from browning adipose tissue regulate systemic metabolism to resist obesity
Amount £704,740 (GBP)
Funding ID MR/X009734/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 09/2023 
End 08/2026
 
Description Modulation of mechanically-activated Piezo1 channel by ceramide
Amount £666,518 (GBP)
Funding ID PG/21/10595 
Organisation British Heart Foundation (BHF) 
Sector Charity/Non Profit
Country United Kingdom
Start 03/2022 
End 02/2025
 
Description The role of iron homeostasis and ferroptosis in skeletal muscle dysfunction in type 2 diabetes
Amount £104,000 (GBP)
Funding ID 22/0006464 
Organisation Diabetes UK 
Sector Charity/Non Profit
Country United Kingdom
Start 10/2023 
End 09/2026
 
Title Detergent-Free Simultaneous Sample Preparation Method for Proteomics and Metabolomics 
Description The integration of omics techniques has seen a step change in our understanding of biological systems. However, multiomics has been impaired by mutually exclusive omic separation methods and the destructive nature of the techniques when sample is limited. We describe Simultaneous Trapping (SiTrap), a simple and effective detergent-free method that facilitates direct measurement of the proteome and metabolome in the same sample extract. This "single-pot" multiomics processing is particularly beneficial in cases when sample amounts are limited or are heterogeneous, for example, tissue biopsies. We demonstrate the value of the SiTrap methodology as an essential multiomics tool in a proof-of-principle integrated study of renal cancer tissue biopsy samples. We believe SiTrap has the potential to become an indispensable tool in translational medical research. 
Type Of Material Technology assay or reagent 
Year Produced 2020 
Provided To Others? Yes  
Impact This was developed in partnership with the industrial entity Protifi LLC 
URL https://pubs.acs.org/doi/full/10.1021/acs.jproteome.9b00662
 
Title LipidQuan: Quantifying the Lipidome of Transgenic Mice Tissue Extracts, a Rapid and Comprehensive Targeted Approach 
Description Although advances in mass spectrometry (MS) have allowed for more in-depth lipidomic analysis, unambiguous identification and quantification has proven difficult as lipids exhibit a high number of isomeric and isobaric species. In this application note, we adapt the LipidQuan workflow to provide a comprehensive and quantitative overview of the lipid species from murine adipose tissue extracts. 
Type Of Material Technology assay or reagent 
Year Produced 2020 
Provided To Others? Yes  
Impact This method has been used by a wide range of academic laboratories and was developed in combination with an industrial partner (Waters Corporation). 
URL https://www.waters.com/nextgen/gb/en/library/application-notes/2020/LipidQuan-Quantifying-the-Lipido...
 
Title MTBLS2436: Brown and beige adipose tissue regulate systemic metabolism through a metabolite interorgan signaling axis. 
Description Brown and beige adipose tissue are emerging as distinct endocrine organs. These tissues are functionally associated with skeletal muscle, adipose tissue metabolism and systemic energy expenditure, suggesting an interorgan signaling network. Using metabolomics, we identify 3-methyl-2-oxovaleric acid, 5-oxoproline, and ß-hydroxyisobutyric acid as small molecule metabokines synthesized in browning adipocytes and secreted via monocarboxylate transporters. 3-methyl-2-oxovaleric acid, 5-oxoproline and ß-hydroxyisobutyric acid induce a brown adipocyte-specific phenotype in white adipocytes and mitochondrial oxidative energy metabolism in skeletal myocytes both in vitro and in vivo. 3-methyl-2-oxovaleric acid and 5-oxoproline signal through cAMP-PKA-p38 MAPK and ß-hydroxyisobutyric acid via mTOR. In humans, plasma and adipose tissue 3-methyl-2-oxovaleric acid, 5-oxoproline and ß-hydroxyisobutyric acid concentrations correlate with markers of adipose browning and inversely associate with body mass index. These metabolites reduce adiposity, increase energy expenditure and improve glucose and insulin homeostasis in mouse models of obesity and diabetes. Our findings identify beige adipose-brown adipose-muscle physiological metabokine crosstalk. LC-MS metabolomic dataset from human cells and mouse plasma. 
Type Of Material Database/Collection of data 
Year Produced 2021 
Provided To Others? Yes  
Impact Unknown 
URL https://www.ebi.ac.uk/metabolights/MTBLS2436/descriptors
 
Description Defining the brown adipocyte secretome 
Organisation AstraZeneca
Country United Kingdom 
Sector Private 
PI Contribution We used our LC-MS to define the metabolite and lipid secretome of brown and beige adipocytes and identify secreted metabokine endocrine signals.
Collaborator Contribution The partners at AstraZeneca performed Seahorse respirometry and high resolution immunostaining and microscopy of immortalized human brown adipocytes treated with putative brown adipose tissue metabokines.
Impact Whitehead A, Krause FN, Moran A, MacCannell ADV, Scragg JL, McNally BD, Boateng E, Murfitt SA, Virtue S, Wright J, Garnham J, Davies GR, Dodgson J, Schneider JE, Murray AJ, Church C, Vidal-Puig A, Witte KK, Griffin JL, Roberts LD. Brown and beige adipose tissue regulate systemic metabolism through a metabolite interorgan signaling axis. Nat Commun. 2021 Mar 26;12(1):1905. doi: 10.1038/s41467-021-22272-3. PMID: 33772024; PMCID: PMC7998027.
Start Year 2019
 
Description Defining the lipotoxicity-induced skeletal muscle extracellular vesicle secretome 
Organisation AstraZeneca
Country United Kingdom 
Sector Private 
PI Contribution We used LC-MS lipidomics to define the lipid content of extracellular vesicles released from skeletal myocytes in response to lipotoxicity.
Collaborator Contribution Our collaborators at AstraZeneca used nanosight tracking to evaluate and isolate the extracellular vesicles (both exosomes and microvesicles) from skeletal myocytes exposed to lipotoxicity.
Impact McNally BD, Ashley DF, Hänschke L, Daou HN, Watt NT, Murfitt SA, MacCannell ADV, Whitehead A, Bowen TS, Sanders FWB, Vacca M, Witte KK, Davies GR, Bauer R, Griffin JL, Roberts LD. Long-chain ceramides are cell non-autonomous signals linking lipotoxicity to endoplasmic reticulum stress in skeletal muscle. Nat Commun. 2022 Apr 1;13(1):1748. doi: 10.1038/s41467-022-29363-9. PMID: 35365625; PMCID: PMC8975934.
Start Year 2018
 
Description Hepatectomy risk assessment with LC-MS 
Organisation University of Sheffield
Country United Kingdom 
Sector Academic/University 
PI Contribution We will use LC-MS analysis to measure Gadoxetate in the plasma of patients to assess Hepatectomy risk
Collaborator Contribution Our collaborators have run the clinical study of the Hepatectomy risk paients, Gadoxetate treatement and MRI assessment of the patients.
Impact Elsharif M, Roche M, Wilson D, Basak S, Rowe I, Vijayanand D, Feltbower R, Treanor D, Roberts L, Guthrie A, Prasad R, Gilthorpe MS, Attia M, Sourbron S. Hepatectomy risk assessment with functional magnetic resonance imaging (HEPARIM). BMC Cancer. 2021 Oct 23;21(1):1139. doi: 10.1186/s12885-021-08830-4. PMID: 34688256; PMCID: PMC8541801.
Start Year 2018
 
Description Metabolic analysis of Ceramide Synthase 2 function 
Organisation University of Bonn
Country Germany 
Sector Academic/University 
PI Contribution We performed lipidomic analysis on the CerS2 H/A mouse generated by our partners in Germany and this contributed to published research outputs.
Collaborator Contribution The partners Reinhard Bauer and Lea Hänschke at the University of Bonn generated and supplied us with a transgenic mouse- CerS2 (H/A)- which has transgenic catalytic inactivation of Ceramide Synthase 2.
Impact McNally BD, Ashley DF, Hänschke L, Daou HN, Watt NT, Murfitt SA, MacCannell ADV, Whitehead A, Bowen TS, Sanders FWB, Vacca M, Witte KK, Davies GR, Bauer R, Griffin JL, Roberts LD. Long-chain ceramides are cell non-autonomous signals linking lipotoxicity to endoplasmic reticulum stress in skeletal muscle. Nat Commun. 2022 Apr 1;13(1):1748. doi: 10.1038/s41467-022-29363-9. PMID: 35365625; PMCID: PMC8975934.
Start Year 2020
 
Description Metabolomic analysis of exercise in type 1 diabetes patients 
Organisation Newcastle University
Department Newcastle University Medical School
Country United Kingdom 
Sector Academic/University 
PI Contribution We are performing metabolomic and lipidomic analysis of plasma samples from healthy control and type 1 diabetes patients undergoing an exercise programme in order to understand the effects on exercise in diabetes.
Collaborator Contribution Dr Daniel West at Newcastle University has led the recruitment, exercise programme and plasma sampling of volunteers and type 1 diabetes patients.
Impact Early stages nothing currently to report.
Start Year 2020
 
Description Modulation of mechanically-activated Piezo1 channel by ceramide 
Organisation University of Leeds
Department Leeds School of Medicine
Country United Kingdom 
Sector Academic/University 
PI Contribution We will be using the LC-MS system funded by this grant to analyse the lipid species associated with the membrane protein piezo1 using lipidomics.
Collaborator Contribution This is an grant form the BHF led by PI Dr Jian Shi who is exploring the effects of the lipid species ceramide on the modulation of the calcium channel membrane protein piezo 1.
Impact This is a multidisciplinary award combining artificial intelligence and bioinformatic computer modelling, mass spectrometry lipidomics (analytical chemistry) and patch clamping (biophysics).
Start Year 2022
 
Description MuRFs and muscle dysfunction in heart failure 
Organisation University of Leeds
Department Faculty of Biological Sciences
Country United Kingdom 
Sector Academic/University 
PI Contribution I am using the LC-MS funded by this grant to perform metabolomic and lipidomic analysis on skeletal muscle from patients with chronic heart failure and transgenic mouse models of MuRF 1 and chronic heart failure to understand MuRF1s role in muscle metabolism during heart failure.
Collaborator Contribution My partners are investigating the role of MuRF on skeletal muscle dysfunction and cachexia in chronic heart failure.
Impact Knuiman P, Straw S, Gierula J, Koshy A, Roberts LD, Witte KK, Ferguson C, Bowen TS. Quantifying the relationship and contribution of mitochondrial respiration to systemic exercise limitation in heart failure. ESC Heart Fail. 2021 Apr;8(2):898-907. doi: 10.1002/ehf2.13272. Epub 2021 Feb 20. PMID: 33609003; PMCID: PMC8006730. Wood N, Straw S, Scalabrin M, Roberts LD, Witte KK, Bowen TS. Skeletal muscle atrophy in heart failure with diabetes: from molecular mechanisms to clinical evidence. ESC Heart Fail. 2021 Feb;8(1):3-15. doi: 10.1002/ehf2.13121. Epub 2020 Nov 22. PMID: 33225593; PMCID: PMC7835554. Caspi T, Straw S, Cheng C, Garnham JO, Scragg JL, Smith J, Koshy AO, Levelt E, Sukumar P, Gierula J, Beech DJ, Kearney MT, Cubbon RM, Wheatcroft SB, Witte KK, Roberts LD, Bowen TS. Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy. J Am Heart Assoc. 2020 Sep 15;9(18):e017091. doi: 10.1161/JAHA.120.017091. Epub 2020 Sep 5. PMID: 32892688; PMCID: PMC7727001. Garnham JO, Roberts LD, Espino-Gonzalez E, Whitehead A, Swoboda PP, Koshy A, Gierula J, Paton MF, Cubbon RM, Kearney MT, Egginton S, Bowen TS, Witte KK. Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathology. J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):394-404. doi: 10.1002/jcsm.12515. Epub 2019 Dec 21. PMID: 31863644; PMCID: PMC7113493. Garnham JO, Roberts LD, Caspi T, Al-Owais MM, Bullock M, Swoboda PP, Koshy A, Gierula J, Paton MF, Cubbon RM, Kearney MT, Bowen TS, Witte KK. Divergent skeletal muscle mitochondrial phenotype between male and female patients with chronic heart failure. J Cachexia Sarcopenia Muscle. 2020 Feb;11(1):79-88. doi: 10.1002/jcsm.12488. Epub 2019 Aug 20. PMID: 31430834; PMCID: PMC7015245.
Start Year 2020
 
Description Feature on Diabetes UK Charity Website 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Supporters
Results and Impact This was a feature article on the Diabetes UK website highlighting research published in the journal Nature Communications that had used the equipment funded by this grant. The aim of the feature was to communicate the research to a general audience including public, patients, practitioners and fund raisers. The hope is that this will increase charitable donations to Diabetes UK.
Year(s) Of Engagement Activity 2021
URL https://www.diabetes.org.uk/about_us/news/type-2-fat-burn-signals
 
Description High Levels of Fat in Our Blood May Be Even More Harmful Than We Realized 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact Online news blog describing our research at ScienceAlert.
Year(s) Of Engagement Activity 2022
URL https://www.sciencealert.com/higher-levels-of-blood-fats-are-more-damaging-than-we-thought
 
Description Increased levels of blood fats more harmful than first thought 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact Online news blog describing our research - TechExplorist
Year(s) Of Engagement Activity 2022
URL https://www.techexplorist.com/increased-levels-blood-fats-harmful-first-thought/46172/?utm_source=rs...
 
Description Nursing in Practice article: Research gives obesity and type 2 diabetes hope 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact This was an article in the magazine (online) "Nursing in Practice" reporting our research that had used the equipment funded by this grant.
Year(s) Of Engagement Activity 2021
URL https://www.nursinginpractice.com/clinical/diabetes/research-gives-obesity-and-type-2-diabetes-hope/
 
Description SCIENTISTS UNCOVER HOW OBESITY STRESSES MUSCLE CELLS 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact Online news blog describing our research.
Year(s) Of Engagement Activity 2022
URL https://medicalresearch.com/weight-research/scientists-uncover-how-obesity-stresses-muscle-cells/